Payer PolicyActive
CMM-207: Epidural Adhesiolysis
EVICORE-MSK_ADVANCED-B2D421CC
EviCore by Evernorth
Effective: August 1, 2022
Updated: January 13, 2026
created · Dec 5, 2025
Policy Summary
Epidural adhesiolysis (catheter-based or endoscopic, including caudal, interlaminar, transforaminal, or spinal endoscopy approaches) is considered experimental, investigational, and unproven for treating back pain and therefore not covered; CPT codes 62263, 62264, 62280, 62281, and 62282 are listed as EIU. The guideline cites insufficient scientific evidence, specifies no approved indications or documentation requirements, and notes that final reimbursement/prior-authorization decisions are determined by the health plan and claims rules.
Coverage Criteria Preview
Key requirements from the full policy
"None — epidural adhesiolysis (performed by catheter or endoscopically) as a treatment for back pain is considered experimental, investigational or unproven (EIU)."
Sign up to see full coverage criteria, indications, and limitations.